NCT00839878 - A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Bangladesh | Crick | Crick

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Bangladesh

N/ACompletedNCT00839878

Novo Nordisk A/S2,092 enrolled

Overview

This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, complications in diabetic subjects in Asia.

Study Type

OBSERVATIONAL

Enrollment

2,092

Conditions

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Interventions

No treatment givenOTHER

Subject will only fill out a questionaire when entering the observational study.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Diabetic patients registered in the particular centre for more than 12 months. * Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit. * Patients willing to sign informed consent form. Exclusion Criteria: * Repetition of any patient as patients should not be included twice for any reason. * Unwilling to participate or unable to comply with protocol requirements.

Locations (1)

Novo Nordisk Investigational Site

Dhaka, Bangladesh

Outcomes

Primary Outcomes

Mean age of onset of type 1 and 2 diabetes mellitus

Time frame: at baseline visit/study start

Mean duration of treatment of type 2 DM

Time frame: at baseline visit/study start

Percentage of patients on Insulin and OAD therapy

Time frame: at baseline visit/study start

Mean duration of diabetes in type 1 and type 2 patients respectively

Time frame: at baseline visit/study start

Mean FPG and PPG of diabetic patients

Time frame: at baseline visit/study start

Mean HbA1c of diabetic patients

Time frame: at baseline visit/study start

Percentage of diabetic patients with HbA1c target below or equal to 7.0%.

Time frame: at baseline visit/study start

Percentage of diabetic patients with HbA1c target below or equal to 6.5%.

Time frame: at baseline visit/study start

Percentage of diabetic patients having dyslipidemia and hypertension

Time frame: at baseline visit/study start

Percentage of diabetic patients having cardiovascular complications

Time frame: at baseline visit/study start

Percentage of diabetic patients having peripheral vascular disease

Time frame: at baseline visit/study start

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.